source
- Study finds nearly 40% of FDA advisory panels include reps linked to pharma-funded advocacy groupsA new analysis published in Health Affairs Scholar examined FDA advisory committee meetings over the past 20 years and found that almost 40% featured a patient or consumer representative with activ…
- Study urges regulators to adopt cloud platforms to speed drug approvalsA new study led by Nina Cauchon of Amgen and co-authors, published in the Journal of Pharmaceutical Sciences, calls for broader use of cloud-based platforms by regulatory agencies. The authors arg…